Ha Tay Pharmaceutical JSC Balance Sheet

Financials in millions VND. Fiscal year is January - December.

Millions VND. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Jan '25 Jan 1, 2025	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Cash & Equivalents	64,786	84,337	90,270	301,790	93,132	59,669
Short-Term Investments	102,550	150,000	90,000	80,000	59,799	362,814
Cash & Short-Term Investments	167,335	234,337	180,270	381,790	152,931	422,483
Cash Growth	-26.32%	29.99%	-52.78%	149.65%	-63.80%	446.74%
Accounts Receivable	112,270	107,755	124,096	89,463	109,915	121,112
Other Receivables	131.94	3,280	2,691	8,412	1,681	19,673
Receivables	112,402	111,035	126,787	97,875	111,596	140,786
Inventory	366,877	513,397	527,935	378,908	460,629	339,706
Other Current Assets	42,987	37,971	89,869	150,099	285,781	104,311
Total Current Assets	689,600	896,739	924,861	1,008,673	1,010,937	1,007,287
Property, Plant & Equipment	984,344	1,000,716	976,101	791,736	442,074	212,752
Long-Term Investments	20,241	19,860	19,336	33,969	11,144	9,486
Other Intangible Assets	1,377	1,377	1,377	1,377	1,593	1,810
Long-Term Deferred Tax Assets	1,043	1,186	-	-	-	-
Other Long-Term Assets	26,597	12,039	4,631	2,510	3,754	6,256
Total Assets	1,723,203	1,931,917	1,926,305	1,838,264	1,469,502	1,237,591
Accounts Payable	209,312	261,261	235,207	146,324	196,573	113,994
Accrued Expenses	20,025	33,500	20,675	12,204	17,119	15,513
Short-Term Debt	146,804	236,151	359,429	333,483	234,630	289,429
Current Portion of Long-Term Debt	13,845	13,845	13,845	-	-	-
Current Income Taxes Payable	3,072	4,550	5,070	4,958	8,660	5,450
Current Unearned Revenue	5,707	6,418	909.3	1,008	785.26	551.02
Other Current Liabilities	106,906	178,298	132,618	98,012	105,374	54,142
Total Current Liabilities	505,671	734,023	767,752	595,988	563,143	479,079
Long-Term Debt	83,068	83,068	96,913	170,218	102,213	-
Other Long-Term Liabilities	3,487	3,626	4,880	4,908	5,306	5,167
Total Liabilities	592,226	820,717	869,545	771,114	670,662	484,245
Common Stock	905,756	905,756	823,418	823,418	264,088	264,088
Additional Paid-In Capital	37,282	37,282	97,320	97,320	315,934	315,934
Retained Earnings	165,856	121,105	90,280	99,006	81,831	79,048
Treasury Stock	-8,084	-8,084	-8,084	-8,084	-8,084	-8,084
Comprehensive Income & Other	2,236	26,612	26,612	26,612	119,572	78,779
Total Common Equity	1,103,046	1,082,671	1,029,546	1,038,273	773,341	729,766
Minority Interest	27,930	28,529	27,214	28,877	25,499	23,580
Shareholders' Equity	1,130,977	1,111,201	1,056,760	1,067,150	798,841	753,345
Total Liabilities & Equity	1,723,203	1,931,917	1,926,305	1,838,264	1,469,502	1,237,591
Total Debt	243,717	333,064	470,187	503,700	336,844	289,429
Net Cash (Debt)	-76,381	-98,727	-289,917	-121,910	-183,912	133,054
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-843.30	-1186.98	-3200.88	-2191.63	-2261.18	1648.53
Filing Date Shares Outstanding	90.57	90.57	90.57	90.57	81.33	81.33
Total Common Shares Outstanding	90.57	90.57	90.57	90.57	81.33	81.33
Working Capital	183,930	162,717	157,109	412,684	447,795	528,208
Book Value Per Share	12178.39	11953.44	11366.87	11463.22	9508.16	8972.40
Tangible Book Value	1,101,670	1,081,295	1,028,170	1,036,896	771,748	727,956
Tangible Book Value Per Share	12163.19	11938.24	11351.67	11448.02	9488.57	8950.14
Buildings	168,480	168,480	165,434	150,724	149,255	148,602
Machinery	275,189	277,573	272,572	234,134	209,230	200,702
Construction In Progress	822,031	827,184	790,110	638,852	301,451	64,931